Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones-Reference-Cited by-同舟云学术

Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones

Published:2016-02 Issue: Volume:65 Page:34-48
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Iasevoli Felice,Giordano Sara,Balletta Raffaele,Latte Gianmarco,Formato Maria Vittoria,Prinzivalli Emiliano,De Berardis Domenico,Tomasetti Carmine,de Bartolomeis Andrea

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference75 articles.

1. A multidimensional (pharmacokinetic and clinical–biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance;Altamura;Schizophr. Res.,1993

2. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am. J. Psychiatry,2005

3. The brief assessment of cognition in schizophrenia. Normative data for the Italian population;Anselmetti;Neurol. Sci.,2008

4. Impact of atypical antipsychotics on quality of life in patients with schizophrenia;Awad;CNS Drugs,2004

5. The practical management of refractory schizophrenia — the Maudsley Treatment REview and Assessment Team service approach;Beck;Acta Psychiatr. Scand.,2014

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction model;Schizophrenia Research;2024-12

2. The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort;Brain Research;2024-12

3. Posterior Cerebellar Resting-State Functional Hypoconnectivity: A Neural Marker of Schizophrenia Across Different Stages of Treatment Response;Biological Psychiatry;2024-09

4. Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates;Australian & New Zealand Journal of Psychiatry;2024-08-28

5. Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition;Frontiers in Psychiatry;2024-08-23